收藏切换
Effect of butylphthalide soft capsules on clinical efficacy in elderly Parkinson's disease patients
收藏切换
Tong FAN1, Bo NING2, *, Xiaojie DAI2, Fangfang HOU2
World Clinical Drug | 2025, 46(4) : 373 - 379
Less
收藏切换
World Clinical Drug | 2025, 46(4): 373-379
• Article •
Effect of butylphthalide soft capsules on clinical efficacy in elderly Parkinson's disease patients
Full
Tong FAN1, Bo NING2, *, Xiaojie DAI2, Fangfang HOU2
Affiliations
  • 1.Department of Neurology, Norinco General Hospital, Xi'an 710065, Shaanxi Province, China
  • 2.Department of Neurology, Xi'an Gaoxin Hospital, Xi'an 710075, Shaanxi Province, China
Published: 2025-04-10 doi: 10.13683/j.wph.2025.04.009
Outline
收藏切换
Objective

To investigate the effects of butylphthalide soft capsules on the cognitive function and clinical efficacy of patients with Parkinson's disease (PD) and cognitive impairment.

Methods

A total of 124 elderly PD patients at Norinco General hospital from January 2021 to January 2022 were selected and randomly divided into control group and observation group, 62 cases in each group. The control group was treated with pramipexole hydrochloride and carbidopa and levodopa sustained-release tablets, while the observation group received the basic treatment combined with oral administration of butylphthalide soft capsules. Neurotransmitters, related factors, cognitive score scales, daily living ability, serum levels of microRNA (miR)-7, miR-128 and miR-221, and the microscopic structure of the left hippocampus of the two groups were analyzed.

Results

After treatment, the levels of norepinephrine, dopamine, 5-hydroxytryptamine and acetylcholine in both groups were increased, and the observation group was higher than the control group (P<0.05). The levels of PD protein 7, and miR-221 in both groups were decreased, and the observation group was lower than the control group (P<0.05). The levels of neurotrophin-3, brain-derived neurotrophic factor, mini-mental state examination, Montreal cognitive assessment, activity of daily living score, miR-7, miR-128, neurite orientation dispersion index and intracellular volume fraction were increased, and the observation group was higher than the control group (P<0.05). There was no difference in the incidence of adverse reactions between the two groups (P>0.05).

Conclusion

The butylphthalide soft capsules can effectively improve the cognitive function of patients with PD and cognitive impairment, alleviate the motor symptoms, which is safe and worthy of promotion and clinical application.

Parkinson's disease  /  butylphthalide  /  neurotransmitters  /  neurotrophic factor
樊同, 宁博, 代晓杰, 侯芳芳. 丁苯酞软胶囊对帕金森病伴认知功能障碍患者认知功能和临床疗效的影响. 世界临床药物, 2025 , 46 (4) : 373 -379 . DOI: 10.13683/j.wph.2025.04.009
Tong FAN, Bo NING, Xiaojie DAI, Fangfang HOU. Effect of butylphthalide soft capsules on clinical efficacy in elderly Parkinson's disease patients[J]. World Clinical Drug, 2025 , 46 (4) : 373 -379 . DOI: 10.13683/j.wph.2025.04.009
Year 2025 volume 46 Issue 4
47
12
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2025.04.009
  • Receive Date:2024-12-11
  • Online Date:2026-11-09
  • Published:2025-04-10
Article Data
Affiliations
History
  • Received:2024-12-11
Affiliations
    1.Department of Neurology, Norinco General Hospital, Xi'an 710065, Shaanxi Province, China
    2.Department of Neurology, Xi'an Gaoxin Hospital, Xi'an 710075, Shaanxi Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.04.009
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT